title: Cyclosporine preferentially inhibits clonal deletion of CD8-positive T cells with an MHC class II restricted autoreactive T-cell receptor.
authors.affiliation: Johns Hopkins Bone Marrow Transplant Unit, Baltimore, Maryland.
authors.forename: M E
authors.initials: ME
authors.lastname: Severino
authors.forename: M K
authors.initials: MK
authors.lastname: Laulis
authors.forename: L R
authors.initials: LR
authors.lastname: Horwitz
authors.forename: A D
authors.initials: AD
authors.lastname: Hess
mesh_terms: D000818:Animals; D016026:Bone Marrow Transplantation / Q000276:immunology*; D016827:CD8 Antigens / Q000276:immunology*; D016572:Cyclosporine / Q000494:pharmacology*; D005260:Female; D006086:Graft vs Host Disease / Q000276:immunology; D000949:Histocompatibility Antigens Class II / Q000276:immunology*; D016130:Immunophenotyping; D008212:Lymphocyte Depletion; D051381:Rats; D011917:Rats, Inbred Lew; D016693:Receptors, Antigen, T-Cell, alpha-beta / Q000032:analysis / Q000276:immunology*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*
chemical_list: D016827:CD8 Antigens; D000949:Histocompatibility Antigens Class II; D016693:Receptors, Antigen, T-Cell, alpha-beta; D016572:Cyclosporine